Novartis Investigative Site

Takarazuka, Hyōgo 665-0022

0 studies enrolling now · 1 studies all time

What they study most

Atherosclerosis

Studies at this site

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) — Completed